We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
-1.41%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$84.7M
AUM Growth
-$13.5M
Cap. Flow
-$7.95M
Cap. Flow %
-9.38%
Top 10 Hldgs %
56.12%
Holding
79
New
15
Increased
14
Reduced
18
Closed
21

Top Buys

Rank Stock Value
1
IRMD icon
iRadimed
IRMD
+$3.43M
2
CYNO
Cynosure, Inc. Class A
CYNO
+$1.47M
3
LPSN icon
LivePerson
LPSN
+$1.37M
4
PCYO icon
Pure Cycle
PCYO
+$1.12M
5
SILC icon
Silicom
SILC
+$1.03M

Top Sells

Rank Stock Value
1
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$2.95M
2
ARCT icon
Arcturus Therapeutics
ARCT
+$2.68M
3
BKNG icon
Booking.com
BKNG
+$1.68M
4
FLNA
Filana Therapeutics
FLNA
+$1.6M
5
CPRX
Catalyst Pharmaceutical
CPRX
+$1.52M

Sector Composition

Rank Sector Weight
1 Healthcare 44.42%
2 Technology 19.14%
3 Utilities 9.4%
4 Financials 8.41%
5 Communication Services 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UPI
76
DELISTED
UROPLASTY INC-NEW
UPI
– –
-172,600
Closed -$463K
SPHS
77
DELISTED
Sophiris Bio, Inc.
SPHS
– –
-93,900
Closed -$211K
ETRM
78
DELISTED
EnteroMedics Inc.
ETRM
– –
-286
Closed -$468K
1 2 3
4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Sophrosyne Capital held 79 positions worth $84.7M, down 14% from $98.2M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sophrosyne Capital withdrew a net $7.95M in Q3 2014, closing 21 positions and reducing 18 holdings. Its most notable exit was Booking.com, an estimated $1.68M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 45% a quarter earlier, followed by Technology and Utilities.

Against the trend, Sophrosyne Capital opened a new position in iRadimed worth $2.65M.

  • Sophrosyne Capital's largest Q3 2014 buy was iRadimed: 378,771 shares worth $2.65M.
  • Sophrosyne Capital added most to Pure Cycle in Q3 2014, an estimated $1.12M increase.
  • Sophrosyne Capital's biggest Q3 2014 reduction was BioDelivery Sciences International, Inc., cutting an estimated $2.95M.
  • Sophrosyne Capital fully exited Booking.com in Q3 2014, selling an estimated $1.68M.
  • Sophrosyne Capital's ten largest holdings make up 56% of its $84.7M portfolio in Q3 2014.
  • Sophrosyne Capital opened 15 new positions and closed 21 in Q3 2014.
  • Sophrosyne Capital's portfolio value fell 14% quarter-over-quarter to $84.7M.

Based on Sophrosyne Capital's 13F filing for Q3 2014, filed 14 Nov 2014.